Medical Journals

Biosensor-based Kinetic Characterization of the Interaction Between Hiv-1 Reverse Transcriptase and Non-nucleoside Inhibitors.

Authors:
  • Geitmann Matthis
  • Unge Torsten
  • Danielson U Helena

From: Department of Biochemistry and Organic Chemistry, Box 576, Uppsala University, SE-751 23 Uppsala, Sweden.

Journal of medicinal chemistry

  • Publish Date: Apr 2006
  • ISSN: 0022-2623
  • Volume: 49
  • Issue: 8
  • Pages: 2367-74
  • Medium: Print
  • Language: English
  • Citation (JAMA): Geitmann Matthis, Unge Torsten, Danielson U Helena, et al. Biosensor-based Kinetic Characterization of the Interaction Between Hiv-1 Reverse Transcriptase and Non-nucleoside Inhibitors.. J. Med. Chem. Apr 2006;49:2367-74

Abstract

Details of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors (NNRTIs) have been elucidated using a biosensor-based approach. This initial study was performed with HIV-1 reverse transcriptase mutant K103N, the phenethylthioazolylthiourea compound (PETT) MIV-150, and the three NNRTIs licensed for clinical use: nevirapine, delavirdine, and efavirenz. Mathematical evaluation of the experimental data with several interaction models revealed that the four inhibitors interacted with HIV-1 RT with varying degrees of complexity. The simplest adequate model accounted for two different conformations of the free enzyme, of which only one can bind the inhibitor, consistent with a previously hypothesized population-shift model including a preformation of the NNRTI binding site. In addition, a heterogeneous binding was observed for delavirdine, efavirenz, and MIV-150, indicating that two noncompetitive and kinetically distinct enzyme-inhibitor complexes could be formed. Furthermore, for these compounds, there were indications for ligand-induced conformational changes.

Mesh Headings (Keywords): Benzoxazines, Binding Sites, Biosensing Techniques, Delavirdine, Enzyme Activation, HIV Reverse Transcriptase, Kinetics, Molecular Structure, Nevirapine, Oxazines, Protein Conformation, Pyridines, Reverse Transcriptase Inhibitors, Structure-Activity Relationship, Time Factors, Urea


Check for Full Text / PubMed Unique Identifier (PMID): 16610780


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.